Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more
Smith & Nephew plc (SNNUF) - Total Assets
Latest total assets as of June 2025: $10.69 Billion USD
Based on the latest financial reports, Smith & Nephew plc (SNNUF) holds total assets worth $10.69 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Smith & Nephew plc - Total Assets Trend (1985–2024)
This chart illustrates how Smith & Nephew plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Smith & Nephew plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Smith & Nephew plc's total assets of $10.69 Billion consist of 42.7% current assets and 57.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.0% |
| Accounts Receivable | $1.21 Billion | 11.7% |
| Inventory | $2.38 Billion | 23.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.03 Billion | 10.0% |
| Goodwill | $3.03 Billion | 29.2% |
Asset Composition Trend (1985–2024)
This chart illustrates how Smith & Nephew plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Smith & Nephew plc's current assets represent 42.7% of total assets in 2024, a decrease from 67.9% in 1985.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2024, down from 20.9% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 29.2% of total assets.
Smith & Nephew plc Competitors by Total Assets
Key competitors of Smith & Nephew plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Smith & Nephew plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Smith & Nephew plc generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Smith & Nephew plc generates $ 3.98 in net profit.
Smith & Nephew plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.00 | 2.51 | 2.18 |
| Quick Ratio | 1.40 | 1.11 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.09 Billion | $ 2.68 Billion | $ 1.78 Billion |
Smith & Nephew plc - Advanced Valuation Insights
This section examines the relationship between Smith & Nephew plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.54 |
| Latest Market Cap to Assets Ratio | 1.20 |
| Asset Growth Rate (YoY) | 3.7% |
| Total Assets | $10.35 Billion |
| Market Capitalization | $12.44 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Smith & Nephew plc's assets above their book value (1.20 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Smith & Nephew plc's assets grew by 3.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Smith & Nephew plc (1985–2024)
The table below shows the annual total assets of Smith & Nephew plc from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $10.35 Billion | +3.67% |
| 2023-12-31 | $9.99 Billion | +0.21% |
| 2022-12-31 | $9.97 Billion | -8.74% |
| 2021-12-31 | $10.92 Billion | -0.84% |
| 2020-12-31 | $11.01 Billion | +18.42% |
| 2019-12-31 | $9.30 Billion | +15.39% |
| 2018-12-31 | $8.06 Billion | +2.45% |
| 2017-12-31 | $7.87 Billion | +7.11% |
| 2016-12-31 | $7.34 Billion | +2.47% |
| 2015-12-31 | $7.17 Billion | -1.90% |
| 2014-12-31 | $7.31 Billion | +25.55% |
| 2013-12-31 | $5.82 Billion | +3.14% |
| 2012-12-31 | $5.64 Billion | +18.85% |
| 2011-12-31 | $4.75 Billion | +0.30% |
| 2010-12-31 | $4.73 Billion | +3.68% |
| 2009-12-31 | $4.57 Billion | +1.26% |
| 2008-12-31 | $4.51 Billion | +1.05% |
| 2007-12-31 | $4.46 Billion | +38.07% |
| 2006-12-31 | $3.23 Billion | +8.57% |
| 2005-12-31 | $2.98 Billion | +1.94% |
| 2004-12-31 | $2.92 Billion | +31.35% |
| 2003-12-31 | $2.22 Billion | +11.52% |
| 2002-12-31 | $1.99 Billion | +24.66% |
| 2001-12-31 | $1.60 Billion | +11.22% |
| 2000-12-31 | $1.44 Billion | -9.36% |
| 1999-12-31 | $1.59 Billion | +5.53% |
| 1998-12-31 | $1.50 Billion | +5.29% |
| 1997-12-31 | $1.43 Billion | -1.00% |
| 1996-12-31 | $1.44 Billion | +13.29% |
| 1995-12-31 | $1.27 Billion | -3.74% |
| 1994-12-31 | $1.32 Billion | +1.15% |
| 1993-12-31 | $1.31 Billion | -2.80% |
| 1992-12-31 | $1.34 Billion | -15.04% |
| 1991-12-31 | $1.58 Billion | +3.19% |
| 1990-12-31 | $1.53 Billion | +13.35% |
| 1989-12-31 | $1.35 Billion | +6.28% |
| 1988-12-31 | $1.27 Billion | +3.72% |
| 1987-12-31 | $1.23 Billion | +38.14% |
| 1986-12-31 | $888.50 Million | +38.10% |
| 1985-12-31 | $643.40 Million | -- |